Exploring of N-phthalimide-linked 1,2,3-triazole analogues with promising ­anti-SARS-CoV-2 activity: synthesis, biological screening, and molecular modelling studies

References

• Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, Hu Y, Tao Z-W, Tian J-H, Pei Y-Y, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):1–15.
   Web of Science ®Google Scholar
• Lengerli D, Ibis K, Nural Y, Banoglu E. The 1, 2, 3-triazole ‘all-in-one’ring system in drug discovery: A good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert Opin Drug Discov. 2022;17(11):1209–1236.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y. Thalidomide as a multi-template for development of biologically active compounds. Arch Pharm (Weinheim)). 2008;341(9):536–547.
   PubMed Web of Science ®Google Scholar
• Shinji C, Nakamura T, Maeda S, Yoshida M, Hashimoto Y, Miyachi H. Design and synthesis of phthalimide-type histone deacetylase inhibitors. Bioorg Med Chem Lett. 2005;15(20):4427–4431.
   PubMed Web of Science ®Google Scholar
• Wang F, Yin H, Yue C, Cheng S, Hong M. Syntheses, structural characterization, in vitro cytotoxicities and DNA-binding properties of triphenylantimony di (N-oxy phthalimide) and di (N-oxy succinimide) complexes. J Organomet Chem. 2013;738:35–40.
   Web of Science ®Google Scholar
• Mahmudov I, Demir Y, Sert Y, Abdullayev Y, Sujayev A, Alwasel SH, Gulcin I. Synthesis and inhibition profiles of N-benzyl- and N-allyl aniline derivatives against carbonic anhydrase and acetylcholinesterase – a molecular docking study. Arabian J Chem. 2022;15(3):103645.
   Web of Science ®Google Scholar
• Gümüş M, Babacan ŞN, Demir Y, Sert Y, Koca İ, Gülçin İ. Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors. Arch Pharm (Weinheim)). 2022;355(1):e2100242.
   PubMed Web of Science ®Google Scholar
• Albo Hay Allah MA, Balakit AA, Salman HI, Abdulridha AA, Sert Y. New Heterocyclic Compound as Carbon Steel Corrosion Inhibitor in 1 M H2SO4, High Efficiency at Low Concentration: Experimental and Theoretical Studies. J Adhes Sci Technol. 2023;37(3):525–547.
   Web of Science ®Google Scholar
• Jan JT, Cheng TR, Juang YP, Ma HH, Wu YT, Yang WB, Cheng CW, Chen X, Chou TH, Shie JJ, et al. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021;118(5):e2021579118.
   PubMed Web of Science ®Google Scholar
• Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, et al. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 2022;386(6):509–520.
   PubMed Web of Science ®Google Scholar
• Mahase E. Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;375:n2713.
   PubMed Web of Science ®Google Scholar
• Juang Y-P, Chou Y-T, Lin R-X, Ma H-H, Chao T-L, Jan J-T, Chang S-Y, Liang P-H. Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2. Eur J Med Chem. 2022;235:114295.
   PubMed Web of Science ®Google Scholar
• Malebari AM, Ahmed H EA, Ihmaid SK, Omar AM, Muhammad YA, Althagfan SS, Aljuhani N, Sayed AAE, Halawa A-A, El-Tahir Hm AH, Turkistani SA, et al. Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms. Bioorg Chem. 2023;130:106255.
   PubMed Web of Science ®Google Scholar
• Shyr ZA, Gorshkov K, Chen CZ, Zheng W. Drug discovery strategies for SARS-CoV-2. J Pharmacol Exp Ther. 2020;375(1):127–138.
   PubMed Web of Science ®Google Scholar
• Ouyang G, Chen Z, Cai XJ, Song BA, Bhadury PS, Yang S, Jin LH, Xue W, Hu DY, Zeng S. Synthesis and antiviral activity of novel pyrazole derivatives containing oxime esters group. Bioorg Med Chem. 2008;16(22):9699–9707.
   PubMed Web of Science ®Google Scholar
• Alsehli M, Aljuhani A, Ihmaid SK, El-Messery SM, Othman DIA, El-Sayed A-A, Ahmed HEA, Rezki N, Aouad MR. Design and synthesis of benzene homologues tethered with 1,2,4-triazole and 1,3,4-thiadiazole motifs revealing dual MCF-7/HepG2 cytotoxic activity with prominent selectivity via histone demethylase LSD1 inhibitory effect. Int J Mol Sci. 2022;23(15):8796.
   PubMed Web of Science ®Google Scholar
• Ihmaid SK, Aljuhani A, Alsehli M, Rezki N, Alawi A, Aldhafiri AJ, Salama SA, Ahmed HEA, Aouad MR. Discovery of triaromatic flexible agents bearing 1,2,3-triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics. J Mol Struct. 2022;1249:131568.
   Web of Science ®Google Scholar
• Ihmaid SK, Alraqa SY, Aouad MR, Aljuhani A, Elbadawy HM, Salama SA, Rezki N, Ahmed HEA. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability. Bioorg Chem. 2021;111:104835.
   PubMed Web of Science ®Google Scholar
• Al-Masoudi NA, Abood E, Al-Maliki ZT, Al-Masoudi WA, Pannecouque C. Amino acid derivatives. Part 6. Synthesis, in vitro antiviral activity and molecular docking study of new N-α-amino acid derivatives conjugated spacer phthalimide backbone. Med Chem Res. 2016;25(11):2578–2588.
   Web of Science ®Google Scholar
• Mandić L, Benčić P, Mlinarić-Majerski K, Liekens S, Snoeck R, Andrei G, Kralj M, Basarić N. Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity. Arch Pharm (Weinheim)). 2020;353(6):e2000024.
   PubMed Web of Science ®Google Scholar
• Dege N, Gökce H, Doğan OE, Alpaslan G, Ağar T, Muthu S, Sert Y. Quantum computational, spectroscopic investigations on N-(2-((2-chloro-4, 5-dicyanophenyl) amino) ethyl)-4-methylbenzenesulfonamide by DFT/TD-DFT with different solvents, molecular docking and drug-likeness researches. Colloids Surf, A. 2022;638:128311.
   Google Scholar
• Menati S, Azadbakht R, Rudbari HA, Bruno G. Synthesis and characterization of four new azo-Schiff base and their nickel (II) complexes. Polyhedron. 2021;205:115296.
   Web of Science ®Google Scholar
• Assis SP, da Silva MT, de Oliveira RN, Lima VL. Synthesis and anti-inflammatory activity of new alkyl-substituted phthalimide 1H-1,2,3-triazole derivatives. ScientificWorldJournal. 2012;2012:925925–925927.
   PubMedGoogle Scholar
• Assis SPO, Silva MTD, Silva FTD, Sant’Anna MP, Tenório C, Santos C, Fonseca C, Seabra G, Lima VLM, Oliveira RN. Design and synthesis of triazole-phthalimide hybrids with anti-inflammatory activity. Chem Pharm Bull (Tokyo)). 2019;67(2):96–105.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393.
   PubMed Web of Science ®Google Scholar
• Holanda VN, Lima EMA, Silva WVD, Maia RT, Medeiros RL, Ghosh A, Lima VLM, Figueiredo R. Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study. J Biomol Struct Dyn. 2022;40(12):5462–5480.
   PubMed Web of Science ®Google Scholar
• Abutaleb NS, Elhassanny AE, Nocentini A, Hewitt CS, Elkashif A, Cooper BR, Supuran CT, Seleem MN, Flaherty DP. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J Enzyme Inhib Med Chem. 2022;37(1):51–61.
   PubMed Web of Science ®Google Scholar
• Paulsson-Habegger L, Snabaitis AK, Wren SP. Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection. Bioorg Med Chem. 2021;48:116389.
   PubMed Web of Science ®Google Scholar
• Khan SA, Akhtar MJ, Gogoi U, Meenakshi DU, Das A. An overview of 1,2,3-triazole-containing hybrids and their potential anticholinesterase activities. Pharmaceuticals. 2023;16(2):179.
   Web of Science ®Google Scholar
• Rezki N, Almehmadi MA, Ihmaid S, Shehata AM, Omar AM, Ahmed HEA, Aouad MR. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor ­receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Bioorg Chem. 2020;103:104133.
   PubMed Web of Science ®Google Scholar
• Bozorov K, Zhao J, Aisa HA. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg Med Chem. 2019;27(16):3511–3531.
   PubMed Web of Science ®Google Scholar
• Al-Blewi F, Shaikh SA, Naqvi A, Aljohani F, Aouad MR, Ihmaid S, Rezki N. Design and synthesis of novel imidazole derivatives possessing triazole pharmacophore with potent anticancer activity, and in silico ADMET with GSK-3β molecular docking investigations. Int J Mol Sci. 2021;22(3):1162.
   PubMed Web of Science ®Google Scholar
• Alraqa SY, Alharbi K, Aljuhani A, Rezki N, Aouad MR, Ali I. Design, click conventional and microwave syntheses, DNA binding, docking and anticancer studies of benzotriazole-1,2,3-triazole molecular hybrids with different pharmacophores. J Mol Struct. 2021;1225:129192.
   Web of Science ®Google Scholar
• Almehmadi MA, Aljuhani A, Alraqa SY, Ali I, Rezki N, Aouad MR, Hagar M. Design, synthesis, DNA binding, modeling, anticancer studies and DFT calculations of Schiff bases tethering benzothiazole-1,2,3-triazole conjugates. J Mol Struct. 2021;1225:129148.
   Web of Science ®Google Scholar
• Yahya Alraqa S, Alsayed Soliman M, Aljuhani A, Rezki N, Reda Aouad M, Ali I. Synthesis, characterization, DNA binding, docking, and anticancer studies of novel bis-1,2,3-triazoles phthalonitrile. ChemistrySelect. 2020;5(36):11347–11353.
   Web of Science ®Google Scholar
• Aljuhani A, Almehmadi MA, Barnawi IO, Rezki N, Ali I, Messali M, Reda Aouad M. Microwave versus conventional synthesis, anticancer, DNA binding and docking studies of some 1,2,3-triazoles carrying benzothiazole. Arabian J Chem. 2021;14(3):102997.
   Web of Science ®Google Scholar
• Upadhyay HC. Coumarin-1,2,3-triazole hybrid molecules: an emerging scaffold for combating drug resistance. Curr Top Med Chem. 2021;21(8):737–752.
   PubMed Web of Science ®Google Scholar
• Belay Y, Muller A, Leballo P, Kolawole OA, Adeyinka AS, Fonkui TY, Motadi LR. Molecular hybrid of 1,2,3-triazole and Schiff base as potential antibacterial agents: DFT, molecular docking and ADME studies. J Mol Struct. 2023;1286:135617.
   Web of Science ®Google Scholar
• Zhao S, Liu J, Lv Z, Zhang G, Xu Z. Recent updates on 1,2,3-triazole-containing hybrids with in vivo therapeutic ­potential against cancers: A mini-review. Eur J Med Chem. 2023; 251:115254.
   PubMed Web of Science ®Google Scholar
• Reda Aouad M, Almehmadi MA, Faleh Albelwi F, Teleb M, Tageldin GN, Abu-Serie MM, Hagar M, Rezki N. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation. Bioorg Chem. 2022;124:105816.
   PubMed Web of Science ®Google Scholar
• Aljohani FS, Rezki N, Aouad MR, Elwakil BH, Hagar M, Sheta E, Hussein Mogahed NMF, Bardaweel SK, Hagras NA. Synthesis, characterization and nanoformulation of novel sulfonamide-1,2,3-triazole molecular conjugates as potent antiparasitic agents. Int J Mol Sci. 2022;23(8):4241.
   PubMed Web of Science ®Google Scholar
• Çot A, Çeşme M, Onur S, Aksakal E, Şahin İ, Tümer F. Rational design of 1,2,3-triazole hybrid structures as novel anticancer agents: synthesis, biological evaluation and molecular docking studies. J Biomol Struct Dyn. 2023;41(14):6857–6865.
   PubMed Web of Science ®Google Scholar
• Alzahrani SAS, Nazreen S, Elhenawy AA, Neamatallah T, Mahboob M. Synthesis, biological evaluation, and molecular docking of new benzimidazole-1,2,3-triazole hybrids as antibacterial and antitumor agents. Polycyclic Aromat Compd. 2023; 43(4):3380–3391.
   Web of Science ®Google Scholar
• Şahin İ, Çeşme M, Güngör Ö, Özgeriş FB, Köse M, Tümer F. New sulfonamide derivatives based on 1,2,3-triazoles: synthesis, in vitro biological activities and in silico studies. J Biomol Struct Dyn. 2023;15:1–18.
   Google Scholar
• Musa A, Abulkhair HS, Aljuhani A, Rezki N, Abdelgawad MA, Shalaby K, El-Ghorab AH, Aouad MR. Phenylpyrazolone-1,2,3-triazole hybrids as potent antiviral agents with promising SARS-CoV-2 main protease inhibition potential. Pharmaceuticals (Basel). 2023;16(3):463.
   PubMedGoogle Scholar
• Gupta A, Singh P, Kamble B, Kulkarni A, Chandrasekar MJN. Synthesis, docking and biological evaluation of some novel 5-bromo-2- (5-aryl-1,3,4-thiadiazol-2-yl)isoindoline-1,3-dione derivatives targeting ATP-binding site of topoisomerase II. LDDD. 2012;9(7):668–675.
   Google Scholar
• Lamie P F, Phillopes J N, El-Gendy A O, Rarova L, Gruz J. Design, synthesis and evaluation of novel phthalimide derivatives as in vitro anti-microbial, anti-oxidant and anti-inflammatory agents. Molecules. 2015;20(9):16620–16642.
   PubMed Web of Science ®Google Scholar
• El-Gohary NS, Shaaban MI. Synthesis, antimicrobial, antiquorum-sensing, and cytotoxic activities of new series of isoindoline-1, 3-dione, pyrazolo [5, 1-a] isoindole, and pyridine derivatives. Arch Pharm (Weinheim)). 2015;348(9):666–680.
   PubMed Web of Science ®Google Scholar
• Ahmed HEA, Abdel-Salam HA, Shaker MA. Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1, 3-dione derivatives. Bioorg Chem. 2016;66:1–11.
   PubMed Web of Science ®Google Scholar
• Abdulridha AA, Albo Hay Allah MA, Makki SQ, Sert Y, Salman HE, Balakit AA. Corrosion inhibition of carbon steel in 1 M H2SO4 using new Azo Schiff compound: Electrochemical, gravimetric, adsorption, surface and DFT studies. J Mol Liq. 2020;315:113690.
   Web of Science ®Google Scholar
• Genesig CC-gR-TPa, https://www.genesig.com/assets/files/Path_COVID_19_CE_STED_IFU_Issue_500.pdf,. (accessed 12 March 2022.
   Google Scholar
• Santana PA, Álvarez CA, Valenzuela S, Manchego A, Guzmán F, Tirapegui C, Ahumada M. Stability of ACE2 peptide mimetics and their implications on the application for SARS-CoV2 detection. Biosensors (Basel). 2023;13(4):473–485.
   PubMedGoogle Scholar
• Ahmed HEA, El-Nassag MAA, Hassan AH, Mohamed HM, Halawa AH, Okasha RM, Ihmaid S, Abd El-Gilil SM, Khattab ESAEH, Fouda AM, et al. Developing lipophilic aromatic halogenated fused systems with specific ring orientations, leading to potent anticancer analogs and targeting the c-Src Kinase enzyme. J Mol Struct. 2019;1186:212–223.
   Web of Science ®Google Scholar
• Ahmed HE, El-Nassag MA, Hassan AH, Okasha RM, Ihmaid S, Fouda AM, Afifi TH, Aljuhani A, El-Agrody A, chemistry m. Introducing novel potent anticancer agents of 1H-benzo [f] chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect. J Enzyme Inhib Med Chem. 2018;33(1):1074–1088.
   PubMed Web of Science ®Google Scholar
• Alswah M, Bayoumi A, Elgamal K, Elmorsy A, Ihmaid S, Ahmed H. Design, synthesis and cytotoxic evaluation of novel chalcone derivatives bearing triazolo[4,3-a]-quinoxaline moieties as potent anticancer agents with dual EGFR kinase and tubulin polymerization inhibitory effects. Molecules. 2018;23(1):48.
   Web of Science ®Google Scholar
• Morse JS, Lalonde T, Xu S, Liu WR. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem. 2020;21(5):730–738.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, et al. α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment. J Med Chem. 2020;63(9):4562–4578.
   PubMed Web of Science ®Google Scholar
• Zhu W, Xu M, Chen CZ, Guo H, Shen M, Hu X, Shinn P, Klumpp-Thomas C, Michael SG, Zheng W. Zheng W. Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening. ACS Pharmacol Transl Sci. 2020;3(5):1008–1016.
   PubMedGoogle Scholar
• Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE) Chemical Computing Group M, Quebec, Canada. 2012; http://www.chemcomp.com. Accessed on 30/02/2013.
   Google Scholar
• Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem. 2009;30(16):2785–2791.
   PubMed Web of Science ®Google Scholar
• Douangamath A, Fearon D, Gehrtz P, Krojer T, Lukacik P, Owen CD, Resnick E, Strain-Damerell C, Aimon A, Ábrányi-Balogh P, et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat Commun. 2020;11(1):5047.
   PubMed Web of Science ®Google Scholar
• Sabbah DA, Hajjo R, Bardaweel SK, Zhong HA. An updated review on SARS-CoV-2 main Proteinase (MPro): protein structure and small-molecule inhibitors. Curr Top Med Chem. 2021;21(6):442–460.
   PubMed Web of Science ®Google Scholar
• Sabbah DA, Hajjo R, Bardaweel SK, Zhong HA. An updated review on betacoronavirus viral entry inhibitors: learning from past discoveries to advance COVID-19 drug discovery. Curr Top Med Chem. 2021;21(7):571–596.
   PubMed Web of Science ®Google Scholar
• Pang X, Xu W, Liu Y, Li H, Chen L. The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022. Eur J Med Chem. 2023;257:115491.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Kumar N, Sehrawat H, Yadav N, Mishra V. Click triazole as a linker for drug repurposing against SARs-CoV-2: A greener approach in race to find COVID-19 therapeutic. Current Research in Green and Sustainable Chemistry. 2021;4:100064.
   Google Scholar
• Nukoolkarn V, Lee VS, Malaisree M, Aruksakulwong O, Hannongbua S. Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors. J Theor Biol. 2008;254(4):861–867.
   PubMed Web of Science ®Google Scholar
• Bouamrane S, Khaldan A, Maghat H, Ajana MA, Bouachrine M, Lakhlifi T. Quantitative Structure-Activity Relationships and Molecular Docking studies of 1.2.4 triazole derivatives as antifungal activity. Green and Applied Chemistry. 2020;10:33–48.
   Google Scholar
• Rateb HS, Ahmed HE, Ahmed S, Ihmaid S, Afifi T. Discovery of novel phthalimide analogs: synthesis, antimicrobial and antitubercular screening with molecular docking studies. Excli J. 2016;15:781–796.
   PubMed Web of Science ®Google Scholar
• Remko M. Theoretical study of molecular structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some hypoglycemic agents. J Mol Struct Theochem. 2009;897(1-3):73–82.
   Web of Science ®Google Scholar
• Wang S, Jin G, Wang W, Zhu L, Zhang Y, Dong G, Liu Y, Zhuang C, Miao Z, Yao J, et al. Design, synthesis and structure–activity relationships of new triazole derivatives containing N-substituted phenoxypropylamino side chains. Eur J Med Chem. 2012;53:292–299.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, Abdel-Aziz AA-M, AlSaif NA, Alkahtani HM, Alanazi MM, Obaidullah AJ, Eskandrani RO, Alharbi A. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis. Bioorg Chem. 2020;104:104345.
   PubMed Web of Science ®Google Scholar
• Srivastava R. Theoretical studies on the molecular properties, toxicity, and biological efficacy of 21 new chemical entities. ACS Omega. 2021;6(38):24891–24901.
   PubMed Web of Science ®Google Scholar
• Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharm Res. 2002;19(10):1446–1457.
   PubMed Web of Science ®Google Scholar